{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/30756"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/30756","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Investigating brain structural differences and the impact of common genetic variation across the psychosis spectrum","abstract":"BACKGROUND: Abnormalities in glutamate transmission have been implicated in schizophrenia (SZ). A genome-wide association study (GWAS) associated single nucleotide polymorphisms (SNPs) in glutamate-related genes with the disorder. To elucidate a pathologic role of these variants, this study aims to examine the effects of these SNPs on hippocampal volume. METHOD: Six SNPs from five glutamate-related genes identified by the Psychiatric Genetics Consortium were selected in 279 controls and 284 probands recruited from the B-SNIP study. Hippocampal subfield volumes were extracted from T1 weighted images via the MAGeT pipeline. A mixed model analysis was conducted using SPSS to evaluate a diagnosis by SNP effect on volumes, with site as a random factor, age, sex, and principal component analysis values as fixed factors. P values were adjusted for multiple corrections. RESULTS: rs10520163 (CLCN3), rs2973155 (GRIA1), and rs9922678 (GRIN2A) displayed a significant main effect (p< .01) on bilateral total hippocampal volume. Post hoc comparison revealed individuals homozygous for the risk allele (HZ-Risk) had significantly smaller volumes than those who were homozygous for the non-risk allele (HZ-NoRisk) (p<.01). For the same SNPs, a significant diagnosis-by-genotype interaction (p<.01) was found for bilateral total hippocampal volume. Significant main effects (p<.01) for the same SNPs were found in subfield volumes bilaterally for the CA1, subiculum, and stratum, with HZ-Risk having smaller volumes. CONCLUSION: Our findings suggest CLCN3, GRIA1, and GRIN2A appear to be associated with reductions in bilateral hippocampal total volume and subfield regions, indicating a potential mechanism by which these genes may confer risk for the disorder.","abstract_html":"BACKGROUND: Abnormalities in glutamate transmission have been implicated in schizophrenia (SZ). A genome-wide association study (GWAS) associated single nucleotide polymorphisms (SNPs) in glutamate-related genes with the disorder. To elucidate a pathologic role of these variants, this study aims to examine the effects of these SNPs on hippocampal volume. METHOD: Six SNPs from five glutamate-related genes identified by the Psychiatric Genetics Consortium were selected in 279 controls and 284 probands recruited from the B-SNIP study. Hippocampal subfield volumes were extracted from T1 weighted images via the MAGeT pipeline. A mixed model analysis was conducted using SPSS to evaluate a diagnosis by SNP effect on volumes, with site as a random factor, age, sex, and principal component analysis values as fixed factors. P values were adjusted for multiple corrections. RESULTS: rs10520163 (CLCN3), rs2973155 (GRIA1), and rs9922678 (GRIN2A) displayed a significant main effect (p&lt; .01) on bilateral total hippocampal volume. Post hoc comparison revealed individuals homozygous for the risk allele (HZ-Risk) had significantly smaller volumes than those who were homozygous for the non-risk allele (HZ-NoRisk) (p&lt;.01). For the same SNPs, a significant diagnosis-by-genotype interaction (p&lt;.01) was found for bilateral total hippocampal volume. Significant main effects (p&lt;.01) for the same SNPs were found in subfield volumes bilaterally for the CA1, subiculum, and stratum, with HZ-Risk having smaller volumes. CONCLUSION: Our findings suggest CLCN3, GRIA1, and GRIN2A appear to be associated with reductions in bilateral hippocampal total volume and subfield regions, indicating a potential mechanism by which these genes may confer risk for the disorder.","abstract_has_math":false,"creators":["Ormston, Leighanne"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Dominguez, Maria Isabel"],"committee_chairs":[],"committee_members":[],"year":2018,"date_issued":"2018","date_published":"2018","updated_at":"2026-11-19T02:40:17Z","subjects":["Neurosciences","Schizophrenia"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/30756","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/30756","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F30756","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Dominguez, Maria Isabel"]},{"key":"dc:creator","label":"Author","values":["Ormston, Leighanne"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2018-08-13T18:38:07Z"]},{"key":"dc:date.embargo","label":"Dc Date Embargo","values":["2019-07-03T00:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2018"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2018-07-03T19:01:50Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Neurosciences","Schizophrenia"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/30756"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["BACKGROUND: Abnormalities in glutamate transmission have been implicated in schizophrenia (SZ). A genome-wide association study (GWAS) associated single nucleotide polymorphisms (SNPs) in glutamate-related genes with the disorder. To elucidate a pathologic role of these variants, this study aims to examine the effects of these SNPs on hippocampal volume. METHOD: Six SNPs from five glutamate-related genes identified by the Psychiatric Genetics Consortium were selected in 279 controls and 284 probands recruited from the B-SNIP study. Hippocampal subfield volumes were extracted from T1 weighted images via the MAGeT pipeline. A mixed model analysis was conducted using SPSS to evaluate a diagnosis by SNP effect on volumes, with site as a random factor, age, sex, and principal component analysis values as fixed factors. P values were adjusted for multiple corrections. RESULTS: rs10520163 (CLCN3), rs2973155 (GRIA1), and rs9922678 (GRIN2A) displayed a significant main effect (p< .01) on bilateral total hippocampal volume. Post hoc comparison revealed individuals homozygous for the risk allele (HZ-Risk) had significantly smaller volumes than those who were homozygous for the non-risk allele (HZ-NoRisk) (p<.01). For the same SNPs, a significant diagnosis-by-genotype interaction (p<.01) was found for bilateral total hippocampal volume. Significant main effects (p<.01) for the same SNPs were found in subfield volumes bilaterally for the CA1, subiculum, and stratum, with HZ-Risk having smaller volumes. CONCLUSION: Our findings suggest CLCN3, GRIA1, and GRIN2A appear to be associated with reductions in bilateral hippocampal total volume and subfield regions, indicating a potential mechanism by which these genes may confer risk for the disorder."]},{"key":"dc:title","label":"Title","values":["Investigating brain structural differences and the impact of common genetic variation across the psychosis spectrum"]}]}],"canonical_facts":{"dc:contributor.advisor":["Dominguez, Maria Isabel"],"dc:creator":["Ormston, Leighanne"],"dc:date.accessioned":["2018-08-13T18:38:07Z"],"dc:date.embargo":["2019-07-03T00:00:00Z"],"dc:date.issued":["2018"],"dc:date.updated":["2018-07-03T19:01:50Z"],"dc:description.abstract":["BACKGROUND: Abnormalities in glutamate transmission have been implicated in schizophrenia (SZ). A genome-wide association study (GWAS) associated single nucleotide polymorphisms (SNPs) in glutamate-related genes with the disorder. To elucidate a pathologic role of these variants, this study aims to examine the effects of these SNPs on hippocampal volume. METHOD: Six SNPs from five glutamate-related genes identified by the Psychiatric Genetics Consortium were selected in 279 controls and 284 probands recruited from the B-SNIP study. Hippocampal subfield volumes were extracted from T1 weighted images via the MAGeT pipeline. A mixed model analysis was conducted using SPSS to evaluate a diagnosis by SNP effect on volumes, with site as a random factor, age, sex, and principal component analysis values as fixed factors. P values were adjusted for multiple corrections. RESULTS: rs10520163 (CLCN3), rs2973155 (GRIA1), and rs9922678 (GRIN2A) displayed a significant main effect (p< .01) on bilateral total hippocampal volume. Post hoc comparison revealed individuals homozygous for the risk allele (HZ-Risk) had significantly smaller volumes than those who were homozygous for the non-risk allele (HZ-NoRisk) (p<.01). For the same SNPs, a significant diagnosis-by-genotype interaction (p<.01) was found for bilateral total hippocampal volume. Significant main effects (p<.01) for the same SNPs were found in subfield volumes bilaterally for the CA1, subiculum, and stratum, with HZ-Risk having smaller volumes. CONCLUSION: Our findings suggest CLCN3, GRIA1, and GRIN2A appear to be associated with reductions in bilateral hippocampal total volume and subfield regions, indicating a potential mechanism by which these genes may confer risk for the disorder."],"dc:identifier.uri":["https://hdl.handle.net/2144/30756"],"dc:language.iso":["en_US"],"dc:subject":["Neurosciences","Schizophrenia"],"dc:title":["Investigating brain structural differences and the impact of common genetic variation across the psychosis spectrum"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-19T02:40:17Z"}